RxDoctor Payments Data

Rex Benjamin Cabaltica, MD

Family Medicine · West Columbia, SCNPI 1942221494

Payments from drug & device makers

$209in general payments, 2019–2025

Across 15 payments — averaging $13.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$42
  • Merck$39
  • Avanir Pharmaceuticals, Inc.$26
  • Neos Therapeutics, LP$25
  • AstraZeneca$23
  • GSK$15
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$209100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$209 in reported general payments places this provider in the 35th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$61,051
Medicare patients
271
Services billed
613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban207$93,651
TrulicityDulaglutide23$23,720
XareltoRivaroxaban46$23,350
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$20,293
JardianceEmpagliflozin34$18,596
JanuviaSitagliptin Phosphate34$17,413
MyrbetriqMirabegron38$16,186
FarxigaDapagliflozin Propanediol26$14,922
EntrestoSacubitril/Valsartan21$9,352
LinzessLinaclotide17$9,088
Lantus SolostarInsulin Glargine,hum.Rec.Anlog156$7,565
Atorvastatin Calcium392$7,400
Breo ElliptaFluticasone/Vilanterol17$6,931
ErtapenemErtapenem Sodium29$6,114
Gabapentin275$5,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$93,651207 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$15$31,50770 claims
Boehringer IngelheimJardiance$42$18,59634 claims
MerckJanuvia$39$17,41334 claims
AstraZenecaFarxiga$23$14,92226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →